Of note, the pathogenic Th17 cells expanding in the reduced IL-2 milieu appeared to be selectively resistant to Treg-mediated inhibition [66,67], thus strengthening chronic inflammation in autoimmunity. The gene discussed is IL2; the disease is Autoimmunity.